Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2000
11/09/2000DE19919751A1 Stabile, wäßrige Dispersionen und stabile, wasserdispergierbare Trockenpulver von Xanthophyllen, deren Herstellung und Verwendung Stable, aqueous dispersions and stable, water-dispersible dry powder of xanthophylls, their preparation and use
11/09/2000CA2727692A1 Isoflavone metabolites
11/09/2000CA2388658A1 1-amino triazolo[4,3-a]quinazolin-5-ones and or -5-thiones inhibiting phosphodiesterase iv
11/09/2000CA2372977A1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a
11/09/2000CA2372948A1 Method of enhancing insulin action
11/09/2000CA2372923A1 Dna encoding snorf36a and snorf36b receptors
11/09/2000CA2372841A1 Amplification of folate-mediated targeting to tumor cells using polymers
11/09/2000CA2372834A1 Amplification of folate-mediated targeting to tumor cells using nanoparticles
11/09/2000CA2372806A1 Intravenous valproate for acute treatment of migraine headache
11/09/2000CA2372773A1 Contraceptive compositions containing antiprogestinic and progestinic
11/09/2000CA2372772A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/09/2000CA2372768A1 Contraceptive compositions containing cyclic urea and amide derivatives
11/09/2000CA2372611A1 Quinones for treatment of diseases
11/09/2000CA2372595A1 Contraceptive compositions containing indoline derivatives and progestational agents
11/09/2000CA2372591A1 Contraceptive compositions containing 3,3-substituted indoline derivatives and uses thereof
11/09/2000CA2372586A1 Contraceptive compositions containing 2,1-benzisothiazoline 2,2-dioxides and progestationals
11/09/2000CA2372493A1 Steroid derivatives
11/09/2000CA2372490A1 Monofluoroalkyl derivatives
11/09/2000CA2372448A1 Use of macrolide compounds for the treatment of dry eye
11/09/2000CA2372387A1 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2372342A1 3.alpha.-hydroxy-3.beta. methoxymethyl-21-heterocycle substituted steroids with anesthetic activity
11/09/2000CA2372279A1 Compositions containing benzimidazolones and progestogens
11/09/2000CA2372229A1 Folic acid supplement
11/09/2000CA2372225A1 Anti-nausea compositions and methods
11/09/2000CA2372223A1 Use of phyllanthus for targeted stimulation of the immune system
11/09/2000CA2372220A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes
11/09/2000CA2372190A1 Methods for the treatment of neuronal atrophy-associated dementia
11/09/2000CA2372176A1 Novel prolines as antimicrobial agents
11/09/2000CA2372173A1 Glucocorticoid receptor modulators
11/09/2000CA2372083A1 Anticonvulsant derivatives useful in treating cocaine dependency
11/09/2000CA2372079A1 Novel catechols as antimicrobial agents
11/09/2000CA2372077A1 A method for the prevention of ischemic spinal cord injury caused by aortic crossclamping
11/09/2000CA2372073A1 Glycine cleavage system inhibitors as potential antipsychotics
11/09/2000CA2371758A1 2,1-benzisothiazoline 2,2-dioxides
11/09/2000CA2371757A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000CA2371726A1 Cyclocarbamate derivatives as progesterone receptor modulators
11/09/2000CA2371671A1 Pyrimidinone compounds
11/09/2000CA2371653A1 Antioxidative vitamin b6 analogs
11/09/2000CA2371651A1 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
11/09/2000CA2371642A1 Cyclic urea and cyclic amide derivatives
11/09/2000CA2371638A1 Indoline derivatives as progesterone antagonists
11/09/2000CA2371635A1 Use of antiprogestagens in combined therapy
11/09/2000CA2371633A1 Thio-oxindole derivatives
11/09/2000CA2371632A1 Cyclocarbamate and cyclic amide derivatives
11/09/2000CA2371629A1 3,3-substituted indoline derivatives
11/09/2000CA2371621A1 Substituted indole sulfonamides as antiviral agents
11/09/2000CA2371604A1 Integrin receptor antagonists
11/09/2000CA2371483A1 Liposome compositions for improved drug retention
11/09/2000CA2371391A1 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's)
11/09/2000CA2371284A1 6-¬¬(aryl and heteroaryl)oxy| methyl|naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof
11/09/2000CA2371271A1 9h-pyrimido¬4,5-b|indole derivatives: crf1 specific ligands
11/09/2000CA2371231A1 Pharmaceutical composition in unit form containing acetylsalicylic acid and clopidogrel hydrogenosulphate
11/09/2000CA2371215A1 New compounds
11/09/2000CA2371034A1 Non-aqueous liquid shampoo composition
11/09/2000CA2371032A1 Neisseria genomic sequences and methods of their use
11/09/2000CA2370821A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/09/2000CA2370633A1 Method of improving the aesthetic appearance of epithelia
11/09/2000CA2370252A1 Cancer treatment with endothelin receptor antagonists
11/09/2000CA2370177A1 Methods for the identification of compounds for the treatment of alzheimer's disease
11/09/2000CA2369550A1 Methods and formulations for targeting infectious agents bearing host cell proteins
11/09/2000CA2369526A1 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000CA2369357A1 2r,4s-hydroxyitraconazole isomers
11/09/2000CA2369077A1 Contraceptive compositions containing quinazolinone and benzoxazine derivatives
11/09/2000CA2368801A1 Conjugates as therapies for cancer and prostate diseases
11/09/2000CA2368779A1 Contraceptive compositions containing cyclic carbamates and amide derivatives
11/09/2000CA2368748A1 X-ray guided drug delivery
11/09/2000CA2368249A1 3-deoxy-desmycosin derivatives and process for their preparation
11/09/2000CA2366805A1 Benzimidazolones and analogues and their use as progesterone receptor ligands
11/09/2000CA2365900A1 Pegylated interferon alfa-ccr5 antagonist combination hiv therapy
11/09/2000CA2365782A1 Treatment of female arousal disorder
11/09/2000CA2365776A1 Method for treating abnormal cell proliferation in the brain
11/09/2000CA2365440A1 Human ion channel proteins
11/09/2000CA2365258A1 Heteroaryl diazabicycloalkanes, their preparation and use
11/09/2000CA2365212A1 Substituted 3-cyano-[1.7],[1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases
11/09/2000CA2336362A1 Anti-irritant compositions containing a cyclic 2'-deoxy-nucleotide
11/09/2000CA2335966A1 Method for inducing growth and enhancing survival of nervous tissue
11/08/2000EP1050535A1 Fused pyrazine compounds
11/08/2000EP1050534A1 2,3-methano-amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
11/08/2000EP1050531A1 Pyridine and piperidine derivatives for treating neurodegenerative diseases
11/08/2000EP1050530A1 1-Aza-2-alkyl-6-aryl-cycloalkanes usefull as memory enhancers
11/08/2000EP1050525A1 Substances capable of inducing apoptosis
11/08/2000EP1050310A1 Minoxidil-containing liquid preparation composition
11/08/2000EP1050309A1 Neurotrophic factor secretion promoters
11/08/2000EP1050308A1 Preventives or remedies for vision disorders
11/08/2000EP1050303A2 Methods and compositions for treating age-related behavioral disorders in companion animals
11/08/2000EP1050302A1 Method for treating abnormal cell proliferation in the brain
11/08/2000EP1050301A1 Medicinal compositions
11/08/2000EP1050300A2 Selective antibacterial composition
11/08/2000EP1050299A1 Fluorometholone suspension eye drops
11/08/2000EP1050298A2 Composition for treating and/or ameliorating the diseases of dandruff, seborrheic dermatitis, psoriasis and eczema and symptoms thereof
11/08/2000EP1050296A1 Composition containing at least a bicyclic aromatic compound and at least a lipopholic sunscreen, and its uses
11/08/2000EP1049793A2 Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
11/08/2000EP1049782A1 Mutants of il-16, processes for their production, and their use
11/08/2000EP1049780A1 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/08/2000EP1049776A1 Phagocytosis genes and uses thereof
11/08/2000EP1049774A2 Promoter regions of the mouse and human telomerase rna component genes
11/08/2000EP1049773A1 Inhibition of cytokine production
11/08/2000EP1049772A1 Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth
11/08/2000EP1049721A1 Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same
11/08/2000EP1049707A1 Ustilipides, method for the production and the use thereof
1 ... 6213 6214 6215 6216 6217 6218 6219 6220 6221 6222 6223 6224 6225 6226 6227 6228 6229 6230 6231 6232 6233 ... 7860